Acute kidney injury clinical trial design: Old problems, new strategies

Pediatric Nephrology

Volumn 28, Issue 2, 2013, Pages 207-217

  Endre, Zoltán H ^a,b,c   Pickering, John W ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Acute kidney injury; Biomarkers; Early intervention; Late intervention; Phase specific renal injury

Indexed keywords

ALKALINE PHOSPHATASE; ALLOPURINOL; ALPHA TOCOPHEROL; ASCORBIC ACID; ATORVASTATIN; CREATININE; CYSTATIN C; DOPAMINE; ERYTHROPOIETIN; FENOLDOPAM; FUROSEMIDE; GAMMA GLUTAMYLTRANSFERASE; IMMUNOGLOBULIN G; KIDNEY INJURY MOLECULE 1; LIOTHYRONINE; MANNITOL; MULTIVITAMIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; NITROPRUSSIDE SODIUM; PYRUVIC ACID; ROLOFYLLINE; SOMATOMEDIN C; THEOPHYLLINE; THYROXINE; ZINC;

ACUTE KIDNEY FAILURE; CLINICAL TRIAL (TOPIC); COMPARATIVE EFFECTIVENESS; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG EFFICACY; DRUG MEGADOSE; EARLY DIAGNOSIS; EARLY INTERVENTION; EMPIRICISM; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HUMAN; INJURY SEVERITY; ISCHEMIC PRECONDITIONING; KIDNEY BLOOD FLOW; KIDNEY CONCENTRATING CAPACITY; KIDNEY GRAFT; NEPHROTOXICITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL REPLACEMENT THERAPY; REPERFUSION INJURY; REVIEW; STUDY DESIGN; TREATMENT OUTCOME; URINE VOLUME;

ACUTE KIDNEY INJURY; BIOLOGICAL MARKERS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 84875850413     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-012-2171-3     Document Type: Review

References (89)

1. Jo S-K, Rosner MH, Okusa MD (2007) Pharmacologic treatment of acute kidney injury: why drugs haven't worked and what is on the horizon. Clin J Am Soc Nephrol 2:356-365
2. Pickering JW, Ralib AM, Nejat M, Endre ZH (2011) New considerations in the design of clinical trials of acute kidney injury. Clin Invest 1:637-650
3. Palmer SC, Sciancalepore M, Strippoli GFM (2011) Trial quality in nephrology: how are we measuring up? Am J Kid Dis 58:335-337
4. Endre ZH, Pickering JW (2010) Outcome definitions in non-dialysis intervention and prevention trials in acute kidney injury (AKI). Nephrol Dial Transplant 25:107-118
5. Song YR, Lee T, You SJ, Chin HJ, Chae D-W, Cheong L, Park K-H, Han S, Kim J-H, Na KY (2009) Prevention of acute kidney injury by erythropoietin in patients undergoing coronary artery bypass grafting: A pilot study. Am J Nephrol 30:253-260
6. Ejaz AA, Martin TD, Johnson RJ, Winterstein AG, Klodell CT, Hess PJ, Ali AK, Whidden EM, Staples NL, Alexander JA, House-Fancher MA, Beaver TM (2009) Prophylactic nesiritide does not prevent dialysis or all-cause mortality in patients undergoing high-risk cardiac surgery. J Thorac Cardiovasc Surg 138:959-964
7. Mentzer RM, Oz MC, Sladen RN, Graeve AH, Hebeler RF Jr, Luber JM Jr, Smedira NG, NAPA Investigators (2007) Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery:the NAPA Trial. J Am Coll Cardiol 49:716-726 (Pubitemid 46205038)
8. Sezai A, Hata M, Niino T, Yoshitake I, Unosawa S, Wakui S, Osaka S, Takayama T, Kasamaki Y, Hirayama A, Minami K (2009) Influence of continuous infusion of low-dose human atrial natriuretic peptide on renal function during cardiac surgery: A randomized controlled study. J Am Coll Cardiol 54:1058-1064
9. Ranucci M, Soro G, Barzaghi N, Locatelli A, Giordano G, Vavassori A, Manzato A, Melchiorri C, Bove T, Juliano G, Uslenghi MF (2004) Fenoldopam prophylaxis of postoperative acute renal failure in high-risk cardiac surgery patients. Ann Thorac Surg 78:1332-1337 (Pubitemid 39303858)
10. Morelli A, Ricci Z, Bellomo R, Ronco C, Rocco M, Conti G, de Gaetano A, Picchini U, Orechhioni A, Portieri M, Coluzzi F, Porzi P, Serio P, Bruno A, Pietropaoli P (2005) Prophylactic fenoldopam for renal protection in sepsis: A randomized, double-blind, placebo-controlled pilot trial. Crit Care Med 33:2451-2456 (Pubitemid 41682094)
11. van Valenberg PL, Hoitsma AJ, Tiggeler RG, Berden JH, van Lier HJ, Koene RA (1987) Mannitol as an indispensable constituent of an intraoperative hydration protocol for the prevention of acute renal failure after renal cadaveric transplantation. Transplantation 44:784-788 (Pubitemid 18034279)
12. Zimmerman RF, Ezeanuna PU, Kane JC, Cleland CD, Kempananjappa TJ, Lucas FL, Kramer RS (2011) Ischemic preconditioning at a remote site prevents acute kidney injury in patients following cardiac surgery. Kidney Int 80:861-867
13. Akamatsu N, Sugawara Y, Tamura S, Kaneko J, Togashi J, Kishi T, Imamura H, Kokudo N, Makuuchi M (2005) Prevention of renal impairment by continuous infusion of human atrial natriuretic peptide after liver transplantation. Transplantation 80:1093-1098 (Pubitemid 41611933)
14. Cogliati AA, Vellutini R, Nardini A, Urovi S, Hamdan M, Landoni G, Guelfi P (2007) Fenoldopam infusion for renal protection in high-risk cardiac surgery patients: A randomized clinical study. J Cardiothorac Vasc Anesth 21:847-850 (Pubitemid 350192281)
15. Halpenny M, Lakshmi S, O'Donnell A, O'Callaghan-Enright S, Shorten G (2001) Fenoldopam: renal and splanchnic effects in patients undergoing coronary artery bypass grafting. Anaesthesia 56:953-960 (Pubitemid 34023656)
16. Kaya K, Oǧuz M, Akar AR, Durdu S, Aslan A, Ertuk S, Tasoz R, Ozyurda U (2007) The effect of sodium nitroprusside infusion on renal function during reperfusion period in patients undergoing coronary artery bypass grafting: A prospective randomized clinical trial. Eur J Cardiothorac Surg 31:290-297 (Pubitemid 46150072)
17. Franklin SC, Moulton M, Sicard GA, Hammerman MR, Miller SB (1997) Insulin-like growth factor I preserves renal function postoperatively. Am J Physiol 272:F257-F259
18. Heemskerk S, Masereeuw R, Moesker O, Bouw MPWJM, van der Hoeven JG, Peters WH, Russel FG, Pickkers P, APSEP Study Group (2009) Alkaline phosphatase treatment improves renal function in severe sepsis or septic shock patients. Crit Care Med 37:417-423
19. Swärd K, Valsson F, Odencrants P, Samuelsson O, Ricksten S-E (2004) Recombinant human atrial natriuretic peptide in ischemic acute renal failure: A randomized placebo-controlled trial. Crit Care Med 32:1310-1315 (Pubitemid 38738585)
20. Givertz MM, Massie BM, Fields TK, Pearson LL, Dittrich HC, CK-201 and CKI-202 Investigators (2007) The effects of KW-3902, an adenosine A1-receptor antagonist, on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance. J Am Coll Cardiol 50:1551-1560 (Pubitemid 47532320)
21. Massie BM, O'Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Weatherley BD, Cleland JGF, Givertz MM, Voors A, DeLucca P, Mansoor GA, Salerno CM, Bloomfield DM, Dittrich HC, PROTECT Investigators and Committees (2010) Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. N Engl J Med 363:1419-1428
22. O'Donnell JL, Smyth D, Frampton C (2005) Prioritizing health-care funding. Int Med J 35:409-412 (Pubitemid 40917439)
23. Bonventre JV, Yang L (2011) Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest 121:4210-4221
24. Endre ZH, Pickering JW, Walker RJ (2011) Clearance and beyond: the complementary roles of GFR measurement and injury biomarkers in acute kidney injury (AKI). Am J Physiol Renal Physiol 301:F697-F707
25. Heyman SN, Rosenberger C, Rosen S (2010) Experimental ischemia-reperfusion: biases and myths - the proximal vs. distal hypoxic tubular injury debate revisited. Kidney Int 77:9-16
26. Jacobs R, Honore PM, Joannes-Boyau O, Boer W, De Regt J, De Waele E, Collin V, Spapen HD (2011) Septic acute kidney injury: the culprit is inflammatory apoptosis rather than ischemic necrosis. Blood Purif 32:262-265
27. Pickering JW, Frampton CM, Endre ZH (2009) Evaluation of trial outcomes in acute kidney injury by creatinine modeling. Clin J Am Soc Nephrol 4:1705-1715
28. Ioannidis J (2005) Why most published research findings are false. PLoS Med 2:696-701
29. Deo A, Schmid CH, Earley A, Lau J, Uhlig K (2011) Loss to analysis in randomized controlled trials in CKD. Am J Kidney Dis 58:349-355
30. Star R (2001) Design issues for clinical trials in acute renal failure. Blood Purif 19:233-237 (Pubitemid 32041360)
31. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky PM, Acute Dialysis Quality Initiative Workgroup (2004) Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8:R204-R212
32. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A, Acute Kidney Injury Network (2007) Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11:R31 (Pubitemid 46604959)
33. KDIGO (Kidney Disease: Improving Global Outcomes) (2012) Section 2: AKI definition. Kidney Int Supp 2:19-36
34. Coller FA, Maddock WG (1935) A study of dehydration in humans. Ann Surg 102:947-960
35. Nejat M, Pickering JW, Devarajan P, Bonventre JV, Edelstein C, Walker RJ, Endre ZH (2012) Some acute kidney injury biomarkers are increased in pre-renal AKI. Kidney Int. doi: 10.1038/ki.2012.23
36. Bellomo R, Bagshaw SM, Langenberg C, Ronco C (2007) Pre-renal azotemia: A flawed paradigm in critically ill septic patients? Contrib Nephrol 156:1-9
37. Kellum JA, Ronco C, Vincent JL (2011) Unveiling current controversies in acute kidney injury. Contrib Nephrol 174:1-3
38. Mishra J, Dent CL, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J, Mori K, Barasch JM, Devarajan P (2005) Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365:1231-1238 (Pubitemid 40469655)
39. Endre ZH, Walker RJ, Pickering JW, Shaw GM, Frampton CM, Henderson SJ, Hutchison R, Mehrtens JE, Robinson JM, Schollum JBW, Westhuyzen J, Celi LA, McGinley RJ, Campbell IJ, George PM (2010) Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial). Kidney Int 77:1020-1030
40. Allgren RL, Marbury TC, Rahman SN, Weisberg LS, Fenves AZ, Lafayette RA, Sweet RM, Center FC, Kurnik BR, Conger JD, Sayegh MH (1997) Anaritide in acute tubular necrosis. Auriculin Anaritide Acute Renal Failure Study Group. N Engl J Med 336:828-834 (Pubitemid 27132980)
41. Johnson DW, Pat B, Vesey DA, Guan Z, Endre ZH, Gobe GC (2006) Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure. Kidney Int 69:1806-1813 (Pubitemid 43739209)
42. Gil H-W, Yang J-O, Lee E-Y, Hong S-Y (2009) Clinical implication of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 in patients with acute paraquat intoxication. Clin Toxicol 47:870-875
43. Gaspari F, Cravedi P, Mandalà M, Perico N, de Leon FR, Stucci N, Ferrari S, Labianca R, Remuzzi G, Ruggenenti P (2010) Predicting cisplatin-induced acute kidney injury by urinary neutrophil gelatinase- associated lipocalin excretion: A pilot prospective case-control study. Nephron Clin Pract 115:c154-c160
44. Mcilroy DR, Wagener G, Lee HT (2010) Neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery: the effect of baseline renal function on diagnostic performance. Clin J Am Soc Nephrol 5:211-219
45. Endre ZH, Pickering JW, Walker RJ, Devarajan P, Edelstein CL, Bonventre JV, Frampton CM, Bennett MR, Ma Q, Sabbisetti VS, Vaidya VS, Walcher AM, Shaw GM, Henderson SJ, Nejat M, Schollum JBW, George PM (2011) Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function. Kidney Int 79:1119-1130
46. Lipcsey M, Bellomo R (2011) Septic acute kidney injury: hemodynamic syndrome, inflammatory disorder, or both? Crit Care 15:1008
47. Pickering JW, Endre ZH (2010) Back-calculating baseline creatinine with MDRD misclassifies acute kidney injury in the intensive care unit. Clin J Am Soc Nephrol 5:1165-1173
48. Ralib AM, Pickering JW, Shaw GM, Devarajan P, Edelstein CL, Bonventre JV, Endre ZH (2012) Test characteristics of urinary biomarkers depend on quantitation method in acute kidney injury. J Am Soc Nephrol 23:322-333
49. Cruz DN, de Geus HR, Bagshaw SM (2011) Biomarker strategies to predict need for renal replacement therapy in acute kidney injury. Semin Dial 24:124-131
50. Nejat M, Pickering JW, Walker RJ, Westhuyzen J, Shaw GM, Frampton CM, Endre ZH (2010) Urinary cystatin C is diagnostic of acute kidney injury and sepsis, and predicts mortality in the intensive care unit. Crit Care 14:R85
51. Kümpers P, Hafer C, Lukasz A, Lichtinghagen R, Brand K, Filser D, Faulhaber-Walter R, Kielstein JT (2010) Serum neutrophil gelatinase-associated lipocalin at inception of renal replacement therapy predicts survival in critically ill patients with acute kidney injury. Crit Care 14:R9
52. Haase M, Devarajan P, Haase-Fielitz A, Bellomo R, Cruz DN, Wagener G, Krawczeski CD, Koyner JL, Murray P, Zappitelli M, Goldstein SL, Makris K, Ronco C, Martensson J, Martling C-R, Venge P, Siew E, Ware LB, Ilizler TA, Mertens PR (2011) The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury a multicenter pooled analysis of prospective studies. J Am Coll Cardiol 57:1752-1761
53. Ozer JS, Dieterle F, Troth S, Perentes E, Cordier A, Verdes P, Staedtler F, Mahl A, Grenet O, Roth DR, Whal D, Legay F, Holder D, Erdos Z, Vlaskova K, Jin H, Yu Y, Muniappa N, Forest T, Clouse HK, Reynolds S, Bailey WJ, Thudium T, Toper MJ, Skopek TR, Sina JF, Glaab WE, Vonderscher J, Maurer G, Chibout S-D, Sistare FD, Gerhold DL (2010) A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function. Nat Biotechnol 28:486-494
54. Wacholder S, Chanock S, Garcia-Closas M, Ghormli El L, Rothman N (2004) Assessing the probability that a positive report is false: An approach for molecular epidemiology studies. J Natl Cancer Inst 96:434-442 (Pubitemid 38443646)
55. Yu Y, Jin H, Holder D, Ozer JS, Villarreal S, Shughrue P, Hi S, Figueroa DJ, Clouse H, Su M, Muniappa N, Troth SP, Bailey W, Seng J, Aslamkhan AG, Thudium D, Sistare FD, Gerhold DL (2010) Urinary biomarkers trefoil factor 3 and albumin enable early detection of kidney tubular injury. Nat Biotechnol 28:470-477
56. Relton C, Torgerson D, O'Cathain A, Nicholl J (2010) Rethinking pragmatic randomised controlled trials: introducing the "cohort multiple randomised controlled trial" design. Br Med J 340:963-967
57. Luce BR, Kramer JM, Goodman SN, Connor JT, Tunis S, Whicher D, Schwartz JS (2009) Rethinking randomized clinical trials for comparative effectiveness research: the need for transformational change. Ann Intern Med 151:206-209
58. Lee BS, Byun SY, Chung ML, Chang JY, Kim HY, Ai-Rhan E, Kim K-S, Pi S-Y (2010) Effect of furosemide on ductal closure and renal function in indomethacin-treated preterm infants during the early neonatal period. Neonatology 98:191-199
59. Witteles RM, Kao D, Christopherson D, Matsuda K, Vagelos RH, Schreiber D, Fowler MB (2007) Impact of nesiritide on renal function in patients with acute decompensated heart failure and pre-existing renal dysfunction a randomized, double-blind, placebo-controlled clinical trial. J Am Coll Cardiol 50:1835-1840 (Pubitemid 350007964)
60. Gianello P, Carlier M, Jamart J, Hulhoven R, Bernheim J, Bernard A, Ketelslegers JM, Squifflet JP (1995) Effect of 1-28 alpha-h atrial natriuretic peptide on acute renal failure in cadaveric renal transplantation. Clin Transplant 9:481-489
61. Lewis J, Salem MM, Chertow GM, Weisberg LS, McGrew F, Marbury TC, Allgren RL (2000) Atrial natriuretic factor in oliguric acute renal failure. Anaritide Acute Renal Failure Study Group. Am J Kidney Dis 36:767-774
62. Meyer M, Pfarr E, Schirmer G, Uberbacher HJ, Schöpe K, Böhm E, Fluge T, Mentz P, Scigalla P, Forssmann WG (1999) Therapeutic use of the natriuretic peptide ularitide in acute renal failure. Ren Fail 21:85-100 (Pubitemid 29085227)
63. Adabag AS, Ishani A, Koneswaran S, Johnson DJ, Kelly RF, Ward HB, McFalls EO, Bloomfield HE, Chandrashekhar Y (2008) Utility of N-acetylcysteine to prevent acute kidney injury after cardiac surgery: A randomized controlled trial. Am Heart J 155:1143-1149
64. Sisillo E, Ceriani R, Bortone F, Juliano G, Salvi L, Veglia F, Fiorentini C, Marenzi G (2008) N-acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery: A prospective, randomized, clinical trial. Crit Care Med 36:81-86
65. Komisarof JA, Gilkey GM, Peters DM, Koudelka CW, Meyer MM, Smith SM (2007) N-acetylcysteine for patients with prolonged hypotension as prophylaxis for acute renal failure (NEPHRON). Crit Care Med 35:435-441 (Pubitemid 46148533)
66. Ricci Z, Luciano R, Favia I, Garisto C, Muraca M, Morelli S, Di Chiari L, Cogo P, Picardo S (2011) High-dose fenoldopam reduces postoperative neutrophil gelatinase-associated lipocaline and cystatin C levels in pediatric cardiac surgery. Crit Care 15:R160
67. Tumlin JA, Finkel K, Murray P, Samuels J, Cotsonis G, Shaw AD (2005) Fenoldopam mesylate in early acute tubular necrosis: A randomized, double-blind, placebo-controlled clinical trial. Am J Kidney Dis 46:26-34 (Pubitemid 40848430)
68. Myles PS, Buckland MR, Schenk NJ, Cannon GB, Langley M, Davis BB, Weeks AM (1993) Effect of "renal-dose" dopamine on renal function following cardiac surgery. Anaesth Intensive Care 21:56-61 (Pubitemid 23074736)
69. Tang AT, El-Gamel A, Keevil B, Yonan N, Deiraniya AK (1999) The effect of "renal-dose" dopamine on renal tubular function following cardiac surgery: Assessed by measuring retinol binding protein (RBP). Eur J Cardio-Thorac Surg Offic J Eur Assoc Cardio-Thorac Surg 15:717-721, discussion 721-2 (Pubitemid 29251773)
70. Sumeray M, Robertson C, Lapsley M, Bomanji J, Norman AG, Woolfson RG (2001) Low dose dopamine infusion reduces renal tubular injury following cardiopulmonary bypass surgery. J Nephrol 14:397-402 (Pubitemid 33080983)
71. Swygert TH, Roberts LC, Valek TR, Brajtbord D, Brown MR, Gunning TC, Paulsen AW, Ramsay MA (1991) Effect of intraoperative low-dose dopamine on renal function in liver transplant recipients. Anesthesiology 75:571-576
72. Baldwin L, Henderson A, Hickman P (1994) Effect of postoperative low-dose dopamine on renal function after elective major vascular surgery. Ann Intern Med 120:744-747 (Pubitemid 24125294)
73. Gubern JM, Sancho JJ, Simó J, Sitges-Serra A (1988) A randomized trial on the effect of mannitol on postoperative renal function in patients with obstructive jaundice. Surgery 103:39-44 (Pubitemid 18056208)
74. Yallop KG, Sheppard SV, Smith DC (2008) The effect of mannitol on renal function following cardio-pulmonary bypass in patients with normal pre-operative creatinine. Anaesthesia 63:576-582 (Pubitemid 351677333)
75. Bennett-Guerrero E, Swaminathan M, Grigore AM, Roach GW, Aberle LG, Johnston JM, Fink MP (2009) A phase II multicenter double-blind placebo-controlled study of ethyl pyruvate in high-risk patients undergoing cardiac surgery with cardiopulmonary bypass. J Cardiothorac Vasc Anesth 23:324-329
76. Krämer BK, Preuner J, Ebenburger A, Kaiser M, Bergner U, Eilles C, Kammerl MC, Riegger GAJ, Birnbaum DE (2002) Lack of renoprotective effect of theophylline during aortocoronary bypass surgery. Nephrol Dial Transplant 17:910-915 (Pubitemid 34521147)
77. Acker CG, Flick R, Shapiro R, Scantlebury VP, Jordan ML, Vivas C, Greenberg A, Johnson JP (2002) Thyroid hormone in the treatment of post-transplant acute tubular necrosis (ATN). Am J Transplant 2:57-61 (Pubitemid 36306808)
78. Voors AA, Dittrich HC, Massie BM, DeLucca P, Mansoor GA, Metra M, Gotter G, Weatherley BD, Ponikowski P, Teerlink JR, Cleland JGF, O'conner CM, Givertz MM (2011) Effects of the adenosine A1 receptor antagonist rolofylline on renal function in patients with acute heart failure and renal dysfunction: results from PROTECT (Placebo-Controlled Randomized Study of the Selective Adenosine A1 Receptor Antagonist Rolofylline for Patients Hospitalized with Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function). J Am Coll Cardiol 57:1899-1907
79. Hirschberg R, Kopple J, Lipsett P, Benjamin E, Minei J, Albertson T, Mungar M, Metzler M, Zaloga G, Murray M, Lowry S, Conger J, Mckeown W, O'shea M, Baughman RP, Wook K, Haupt M, Kaiser R, Simms H, Warnock D, Summer W, Hintz R, Myers BD, Haenftling K, Capra W (1999) Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure. Kidney Int 55:2423-2432 (Pubitemid 29256497)
80. Hladunewich MA, Corrigan G, Derby GC, Ramaswamy D, Kambham N, Scandling JD, Myers BD (2003) A randomized, placebo-controlled trial of IGF-1 for delayed graft function: A human model to study postischemic ARF. Kidney Int 64:593-602 (Pubitemid 36871931)
81. Cantarovich F, Rangoonwala B, Lorenz H, Verho M, Esnault VLM (2004) High-dose furosemide for established ARF: A prospective, randomized, double-blind, placebo-controlled, multicenter trial. Am J Kidney Dis 44:402-409 (Pubitemid 39164616)
82. Berger M, Soguel L, Shenkin A, Revelly J-P, Pinget C, Baines M, Chiolero R (2008) Influence of early antioxidant supplements on clinical evolution and organ function in critically ill cardiac surgery, major trauma, and subarachnoid hemorrhage patients. Crit Care 12:R101
83. Nouri-Majalan N, Ardakani EF, Forouzannia K, Moshtaghian H (2009) Effects of allopurinol and vitamin E on renal function in patients with cardiac coronary artery bypass grafts. Vasc Health Risk Manag 5:489-494
84. Acker CG, Singh AR, Flick RP, Bernardini J, Greenberg A, Johnson JP (2000) A trial of thyroxine in acute renal failure. Kidney Int 57:293-298 (Pubitemid 30227777)
85. Keane WF, Hirata-Dulas CA, Bullock ML, Ney AL, Guay DR, Kalila RS, Dinarello CA, Halstenson CE, Peterson PK (1991) Adjunctive therapy with intravenous human immunoglobulin G improves survival of patients with acute renal failure. J Am Soc Nephrol 2:841-847
86. Prowle JR, Calzavacca P, Licari E, Ligabo EV, Echeverri JE, Haase M, Haase-Felitz A, Bagshaw SM, Devarajan P, Bellom R (2012) A pilot double-blind, randomized controlled trial of short-term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology 17:215-224
87. Choi YS, Shim JK, Kim JC, Kang K-S, Seo YH, Ahan K-R, Kwak YL (2011) Effect of remote ischemic preconditioning on renal dysfunction after complex valvular heart surgery: A randomized controlled trial. J Thorac Cardiovasc Surg 142:148-154
88. Pickering JW, Endre ZH (2009) Secondary prevention of acute kidney injury. Curr Opin Crit Care 15:488-497
89. Endre ZH (2008) Acute kidney injury: definitions and new paradigms. Adv Chronic Kidney Dis 15:213-221 (Pubitemid 351822594)